Codexi(CDXS.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Codexi
CDXS.US
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc.
633.30 B
CDXS.USMarket value -Rank by Market Cap -/-

Financial Score

21/05/2026 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking36/59
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-68.90%E
    • Profit Margin-40.96%E
    • Gross Margin11.39%E
  • Growth ScoreB
    • Revenue YoY56.76%A
    • Net Profit YoY57.04%B
    • Total Assets YoY0.37%C
    • Net Assets YoY-12.89%E
  • Cash ScoreB
    • Cash Flow Margin58.54%C
    • OCF YoY56.76%A
  • Operating ScoreB
    • Turnover0.6B
  • Debt ScoreD
    • Gearing Ratio66.58%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Codexis: Neutral Stance Maintained as Execution Risks Offset Solid Q1; $2 Price Target Reaffirmed

    Tip Ranks·
    US
    CDXS
    +4.88%
    US
    MRK
    -1.09%
    US
    VHT
    +0.27%
    Tip Ranks·
    US
    CDXS
    +4.88%
    US
    MRK
    -1.09%
    US
    VHT
    +0.27%

    Codexi | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 15.25 M

    Earnings Watch·
    US
    CDXS
    +4.88%
    Earnings Watch·
    US
    CDXS
    +4.88%

    Codexis, Inc. (NASDAQ:CDXS) Short Interest Down 35.6% in March

    Market Beat·
    US
    CDXS
    +4.88%
    US
    BBH
    +0.96%
    US
    FBT
    +2.14%
    Market Beat·
    US
    CDXS
    +4.88%
    US
    BBH
    +0.96%
    US
    FBT
    +2.14%

    Aberdeen Group plc Raises Stake in Codexis, Inc. $CDXS

    Market Beat·
    US
    CDXS
    +4.88%
    US
    CLDX
    +2.49%
    US
    SBIO
    +3.75%
    Market Beat·
    US
    CDXS
    +4.88%
    US
    CLDX
    +2.49%
    US
    SBIO
    +3.75%

    Codexis (CDXS) Gets a Buy from Jefferies

    Tip Ranks·
    US
    IBBQ
    +2.43%
    US
    FBT
    +2.14%
    US
    IBB
    +2.27%
    Tip Ranks·
    US
    IBBQ
    +2.43%
    US
    FBT
    +2.14%
    US
    IBB
    +2.27%
    © 2026 Longbridge｜Disclaimer